PHATHOM PHARMACEUTICAL

8,8700

29-ноября-24 12:45:00

15 мин. задержка

Акции

-0,1000

-1,11%

Сегодняшний диапазон

8,6100 - 9,0129

ISIN

N/A

Источник

NASDAQ

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 май 2021 07:00:04 Источник Nasdaq GlobeNewswire
Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 май 2021 16:48:26 Источник Nasdaq GlobeNewswire
Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 апр 2021 15:01:00 Источник Nasdaq GlobeNewswire
Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 апр 2021 07:00:02 Источник Nasdaq GlobeNewswire
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 мар 2021 15:05:01 Источник Nasdaq GlobeNewswire
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 янв 2021 07:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.